XB-ART-38720
Biochim Biophys Acta
2009 Aug 01;17888:1680-6. doi: 10.1016/j.bbamem.2008.10.009.
Show Gene links
Show Anatomy links
Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.
Gottler LM
,
Ramamoorthy A
.
???displayArticle.abstract???
The growing problem of bacterial resistance to conventional antibiotic compounds and the need for new antibiotics have stimulated interest in the development of antimicrobial peptides (AMPs) as human therapeutics. Development of topically applied agents, such as pexiganan (also known as MSI-78, an analog of the naturally occurring magainin2, extracted from the skin of the African frog Xenopus laevis) has been the focus of pharmaceutical development largely because of the relative safety of topical therapy and the uncertainty surrounding the long-term toxicology of any new class of drug administered systemically. The main hurdle that has hindered the development of antimicrobial peptides is that many of the naturally occurring peptides (such as magainin), although active in vitro, are effective in animal models of infection only at very high doses, often close to the toxic doses of the peptide, reflecting an unacceptable margin of safety. Though MSI-78 did not pass the FDA approval, it is still the best-studied AMP to date for therapeutic purposes. Biophysical studies have shown that this peptide is unstructured in solution, forms an antiparallel dimer of amphipathic helices upon binding to the membrane, and disrupts membrane via toroidal-type pore formation. This article covers functional, biophysical, biochemical and structural studies on pexiganan.
???displayArticle.pubmedLink??? 19010301
???displayArticle.pmcLink??? PMC2726618
???displayArticle.link??? Biochim Biophys Acta
???displayArticle.grants??? [+]
AI054515 NIAID NIH HHS , R01 AI054515-01A1 NIAID NIH HHS , R01 AI054515-02 NIAID NIH HHS , R01 AI054515-03 NIAID NIH HHS , R01 AI054515-04 NIAID NIH HHS , R01 AI054515-05 NIAID NIH HHS , R01 AI054515 NIAID NIH HHS
Species referenced: Xenopus laevis
Genes referenced: magainins
References [+] :
Agerberth,
Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides.
1991, Pubmed
Agerberth, Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. 1991, Pubmed
Baker, Anticancer efficacy of Magainin2 and analogue peptides. 1993, Pubmed , Xenbase
Bals, The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. 1998, Pubmed
Barra, Amphibian skin: a promising resource for antimicrobial peptides. 1995, Pubmed , Xenbase
Bechinger, Detergent-like actions of linear amphipathic cationic antimicrobial peptides. 2006, Pubmed
Bechinger, Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy. 1993, Pubmed , Xenbase
Bessalle, Augmentation of the antibacterial activity of magainin by positive-charge chain extension. 1992, Pubmed , Xenbase
Bevins, Peptides from frog skin. 1990, Pubmed , Xenbase
Boman, Peptide antibiotics and their role in innate immunity. 1995, Pubmed
Brogden, Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? 2005, Pubmed
Chan, Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. 2006, Pubmed
Chang, Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. 2003, Pubmed
Chen, Synthetic magainin analogues with improved antimicrobial activity. 1988, Pubmed , Xenbase
Chongsiriwatana, Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. 2008, Pubmed
Cuervo, The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity. 1988, Pubmed , Xenbase
Dennison, Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships. 2005, Pubmed
Dhople, The human beta-defensin-3, an antibacterial peptide with multiple biological functions. 2006, Pubmed
Dvinskikh, A high-resolution solid-state NMR approach for the structural studies of bicelles. 2006, Pubmed
Dürr, LL-37, the only human member of the cathelicidin family of antimicrobial peptides. 2006, Pubmed
Epand, Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. 2006, Pubmed
Epand, Diversity of antimicrobial peptides and their mechanisms of action. 1999, Pubmed
Fuchs, In vitro antimicrobial activity of MSI-78, a magainin analog. 1998, Pubmed
Ganz, Defensins. Natural peptide antibiotics of human neutrophils. 1985, Pubmed
Ge, In vitro antibacterial properties of pexiganan, an analog of magainin. 1999, Pubmed
Giacometti, Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. 2005, Pubmed
Giacometti, In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 2005, Pubmed
Giovannini, Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones. 1987, Pubmed , Xenbase
Glaser, Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid-state 19F-NMR. 2005, Pubmed
Gottler, Using fluorous amino acids to modulate the biological activity of an antimicrobial peptide. 2008, Pubmed
Gottler, Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. 2008, Pubmed
Gullion, Rotational-echo double-resonance NMR. 1989. 2011, Pubmed
Hallock, An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. 2002, Pubmed
Hallock, Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. 2002, Pubmed
Hallock, MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. 2003, Pubmed , Xenbase
Hancock, Cationic peptides: a new source of antibiotics. 1998, Pubmed
Hancock, The role of cationic antimicrobial peptides in innate host defences. 2000, Pubmed
Harwig, Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. 1996, Pubmed
Henzler Wildman, Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. 2003, Pubmed
Henzler-Wildman, Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. 2004, Pubmed
Hiramatsu, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. 1997, Pubmed
Hoskin, Studies on anticancer activities of antimicrobial peptides. 2008, Pubmed
Huang, Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. 1997, Pubmed
Huang, Molecular mechanism of Peptide-induced pores in membranes. 2004, Pubmed
Imura, Action mechanism of tachyplesin I and effects of PEGylation. 2007, Pubmed
Johnson, Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). 2001, Pubmed
Kandasamy, Binding and insertion of alpha-helical anti-microbial peptides in POPC bilayers studied by molecular dynamics simulations. 2004, Pubmed , Xenbase
Kulkarni, The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. 2006, Pubmed
Lamb, Pexiganan acetate. 1998, Pubmed
Lee, Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. 1989, Pubmed
Lillard, Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. 1999, Pubmed
Ludtke, Cooperative membrane insertion of magainin correlated with its cytolytic activity. 1994, Pubmed , Xenbase
Maloy, Structure-activity studies on magainins and other host defense peptides. 1995, Pubmed
Matsuzaki, Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. 1997, Pubmed , Xenbase
Matsuzaki, Relationship of membrane curvature to the formation of pores by magainin 2. 1998, Pubmed , Xenbase
Matsuzaki, Magainins as paradigm for the mode of action of pore forming polypeptides. 1998, Pubmed , Xenbase
Matsuzaki, Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. 1995, Pubmed , Xenbase
Matsuzaki, An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. 1996, Pubmed , Xenbase
Matsuzaki, Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. 1989, Pubmed , Xenbase
Mecke, Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. 2005, Pubmed
Meng, Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. 2007, Pubmed
Moore, The big and small of drug discovery. Biotech versus pharma: advantages and drawbacks in drug development. 2003, Pubmed
Nakamura, Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. 1988, Pubmed
Navon-Venezia, Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. 2002, Pubmed
Niyonsaba, Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. 2001, Pubmed
Oppenheim, Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. 2003, Pubmed
Oren, Mode of action of linear amphipathic alpha-helical antimicrobial peptides. 1998, Pubmed
Papo, Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. 2006, Pubmed
Papo, New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. 2003, Pubmed
Papo, Host defense peptides as new weapons in cancer treatment. 2005, Pubmed
Pichichero, Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. 2007, Pubmed
Porcelli, Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. 2006, Pubmed
Porcelli, NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. 2008, Pubmed
Porter, Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. 2002, Pubmed , Xenbase
Powers, The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment. 2006, Pubmed
Powers, Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. 2005, Pubmed
Radzishevsky, Improved antimicrobial peptides based on acyl-lysine oligomers. 2007, Pubmed
Radzishevsky, Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. 2005, Pubmed
Ramamoorthy, Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. 2006, Pubmed
Ramamoorthy, Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin. 2006, Pubmed , Xenbase
Ramamoorthy, Nitrogen-14 solid-state NMR spectroscopy of aligned phospholipid bilayers to probe peptide-lipid interaction and oligomerization of membrane associated peptides. 2008, Pubmed
Rugeles, Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. 2003, Pubmed
Schaefer, "Development of REDOR rotational-echo double-resonance NMR" by Terry Gullion and Jacob Schaefer [J. Magn. Reson. 81 (1989) 196-200]. 2011, Pubmed
Selsted, Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. 1992, Pubmed
Shai, Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. 1999, Pubmed , Xenbase
Shai, From innate immunity to de-novo designed antimicrobial peptides. 2002, Pubmed
Shanmugam, The structure of antimicrobial pexiganan peptide in solution probed by Fourier transform infrared absorption, vibrational circular dichroism, and electronic circular dichroism spectroscopy. 2005, Pubmed
Tang, Synthesis of urea oligomers and their antibacterial activity. 2005, Pubmed
Tani, Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. 2000, Pubmed
Thennarasu, Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. 2005, Pubmed
Thennarasu, Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. 2005, Pubmed
Tossi, Amphipathic, alpha-helical antimicrobial peptides. 2000, Pubmed
Tremouilhac, Conditions affecting the re-alignment of the antimicrobial peptide PGLa in membranes as monitored by solid state 2H-NMR. 2006, Pubmed
Tremouilhac, Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin. 2006, Pubmed , Xenbase
Wakamatsu, Dimer structure of magainin 2 bound to phospholipid vesicles. 2002, Pubmed , Xenbase
Wenk, Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. 1998, Pubmed , Xenbase
Westerhoff, Magainins and the disruption of membrane-linked free-energy transduction. 1989, Pubmed , Xenbase
Williams, Raman spectroscopy of synthetic antimicrobial frog peptides magainin 2a and PGLa. 1990, Pubmed , Xenbase
Wu, Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. 1999, Pubmed
Zasloff, Antimicrobial peptides of multicellular organisms. 2002, Pubmed
Zasloff, Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. 1987, Pubmed , Xenbase
Zasloff, Antimicrobial activity of synthetic magainin peptides and several analogues. 1988, Pubmed , Xenbase
Zelezetsky, Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies. 2006, Pubmed